World’s largest study on babies with brain injuries starts in India
Small rise in heart attack protein linked to increased risk of early death
New maths reveals how diseases progress and bacteria develop drug resistance
CDDS researchers work across a wide range of diseases, from infection and inflammation to oncology, cardiovascular disease and neurodegeneration.
View our network of disease experts
The CDDS brings together expertise in new screening technologies, target deconvolution, ultrasensitive biomarker analysis, microfluidic devices, and more.
View technology areas
We are developing small molecule, peptide, biological and cell-based modalities across a wide range of target classes and novel modes of action.
View target classes